l General Information |
Product Name | Clindamycin |
General description | Clindamycin inhibits protein synthesis by acting on the 50S ribosomal, used for the treatment of bacterial infections. |
Synonym | Clindamicina; Clindamycinum; Chlolincocin; Dalacin C; Dalacine; (2~{S},4~{R})-~{N}-[(1~{S},2~{S})-2-chloro-1-[(2~{R},3~{R},4~{S},5~{R},6~{R})-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide |
Purity | ≥98.0%(HPLC) | CAS Number | 18323-44-9 |
Formula | C18H33ClN2O5S | Molecular Weight | 424.981 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or off-white solid |
Solubility(25°C) | DMSO | ≥50mg/mL |
Ethanol | ≥25mg/mL |
Water | ≥25mg/mL |
l Biological Information |
Biochem/Physiol
Actions | Clindamycin is a semisynthetic broad spectrum antibiotic produced by chemical modification of the parent compound lincomycin. Clindamycin dissociates peptidyl-tRNA from the bacterial ribosome, thereby disrupting bacterial protein synthesis. |
Application | 1.Anti-Bacterial Agents 2.Protein Synthesis Inhibitors |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
